NCT00524004View on ClinicalTrials.gov

Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 30, 2007

Primary Completion Date

October 26, 2007

Study Completion Date

October 26, 2007

Conditions
Travelers' Diarrhea
Interventions
BIOLOGICAL

Anti-CsbD Bovine IgG

Three times a day for seven days

OTHER

Placebo

Three times a day for seven days

BIOLOGICAL

Anti-CS17 Bovin IgG

Three times a day for seven days

Trial Locations (2)

21205

Center for Immunization Research, Baltimore

21224

Johns Hopkins Bayview Medicial Center, Inpatient Unit, Baltimore

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT00524004 - Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD | Biotech Hunter | Biotech Hunter